Tx glaucome Flashcards
Staging glaucome selon COS guidelines
Suspect : 1 or more of the following
- IOP > 21 mmHg
- Suspicious C/D asymmetry > 0,2
- Suspicious 24-2 (or similar) VFD
Early :
- Early glaucomatous optic disc features C/D < 0,65
AND/OR
- Mild VFD : Not within 10° of fixation, MD better than - 6 dB
Moderate :
- Moderate glaucomatous optic disc features C/D 0,7-0,85
AND/OR
- Moderate VFD : Not within 10° of fixation, MD -6 to -12 dB
Advanced
- Advanced glaucomatous optic disc features C/D > 0,9
AND/OR
- Advanced VFD : Within 10° of fixation, MD > -12 dB
Target IOP treatment selon COS guidelines
Suspect :
- 24 mmHg
- At 20% reduction from baseline
Early :
- 20 mmHg
- At 25% reduction from baseline
Moderate :
- 17 mmHg
- At 30% reduction from baseline
Advanced :
- 14 mmHg
- At 30% reduction from baseline
Noms génériques et classe des Rx suivant :
- Latanoprost
- Travoprost
- Bimatoprost
Latanoprost :
- Xalatan 0,005%
- Monoprost (PF)
Travoprost : Travatan 0,004%
Bimatoprost :
- Lumigan 0,01%
- Vistitan 0,03 %
Mécanisme d’action des analogues des protaglandines
PRODRUGS that penetrate the cornea and become biologically active after being hydrolyzed by corneal esterase
Increase the UVEOSCLERAL outflow (non conventional pathway)
% Réduction PIO avec des analogues des protaglandines
Reduce IOP by 25-33%
Posologie des analogues des protaglandines
Used once daily : Usually HS
Caractéristique du Latanoprostene bunod
Latanoprostene bunod is unique
Nitric oxide donating PGA
NO increases the trabecular outflow too
1 mmHg reduction in IOP compared to Latanoprost in clinical trials
Adverse effects des analogues des protaglandines
Darkening of the iris
- Increase number of melanosomes within the melanocytes without melanocyte prolifation
- Irreversible
Conjunctival hyperemia : plus commun avec Bimatroprost et Travaprost
Hypertrichiasis
Trichiasis
Districhiasis
Periorbital fat atrophy :
- Deepening of th upper eyelid sulcus
- Upper eyelid ptosis
- Enophtalmos
- Inferior scleral show
Less common :
- Exacerbation of pre-existing cystoid macular edema
- Non-granulomatous anterior uveitis
-reactivation of herpetic keratitis has been reported
Noms commerciales et classe des Rx suivant :
- Timolol 0,25%
- Levobunolol
- Metipranolol
- Betaxolol 0,5%
Beta-bloqueurs
Non-Seletive :
- Timoptic
- Levobunolol
- Metipranolol
Selective : Betoptic
Mécanisme d’action des Beta-bloqueurs
Decrease aqueous production
Mediated through the B2-receptors
Dosing of Beta-bloqueurs
BID but once daily in the morning is available in the Timoptic XE
% Réduction PIO avec les Beta-bloqueurs
IOP reduction of 20-30%
The effect occurs within 1 hour and can last up to 4 weeks after discontinuation of the medication
10-20% of patient treated with topical BB are non-responders (Patients on systemic BB!!)
Extended use may result in tachyphylaxis
Adverse effects of BB
Bronchospasm
Bradycardia
Heart block
Depression
Impotence/Reduced libido
HypoTA
Lethargy
CNS depression
/!\ Be aware in patients with Db = masks the signs and sx of hypoglycemia
Contre-indications des BB
Asthma
Baseline bradycardia or 1st degree heart block
Always ask about asthma and bradyarrhythmia prior to initiation of BB
Betaxolol is safer than the NON-selective BB in patients with asthma
Noms génériques et classe des médicaments suivants :
- Iopidine
- Alphagan
a2-adrénergiques agonistes
Iopidine = Apraclonidine 0,5%
Alphagan = Brimonidine 0,15-0,2%
Mécanisme d’action des a2-adrénergiques agonistes
Decrease aqueous humour production
Lequel des a2-adrénergiques agonistes utilise-t-on le plus : apraclonidine ou brimonidine? Et pourquoi?
Brimonidine is the mostly used a2-adrénergiques agonistes
- Apraclonidine causes more hypersensitivity reaction than Brimonidine
- Apraclonidine hase more tachyphylaxis than Brimonidine
Posologie et efficacité des a2-adrénergiques agonistes
BID - TID dosing
20-30% IOP reduction
Adverse effects of a2-adrénergiques agonistes
Ocular allergic reaction
- Follicular conjunctivitis
- Contact blepharodermatitis
- Apraclonidine > Brimonidine (mais se voit quand même)
- Delayed type hypersensivity
Dry mouth
Lethargy
a1 related side effects (Apraclonidine > Brimonidine)
- Conjunctival vasoconstriction
- Pupillary dilatation
- Lid retraction